Global Immune Thrombocytopenia Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 98 pages | ID: GA272AA1081CEN
QYResearch

Abstracts

This report focuses on the global Immune Thrombocytopenia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immune Thrombocytopenia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• CSL
• Amgen
• F.Hoffmann-La Roche
• Kyowa Hakko Kirin
• Rigel Pharmaceuticals
• Shionogi
• Dova Pharmaceuticals
• Novartis
• Jiangsu Hengrui Pharmaceutical
• Takeda
• Ligand Pharmaceuticals

Market segment by Type, the product can be split into

• Intravenous Immunoglobulins
• Corticosteroids
• Thrombopoietin Receptor Agonists
• Others

Market segment by Application, split into

• Hospitals and Clinics
• Specialty Centers
• Research and Academic Institutes
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Immune Thrombocytopenia Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Immune Thrombocytopenia Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Immune Thrombocytopenia Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Immune Thrombocytopenia Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Immune Thrombocytopenia Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Intravenous Immunoglobulins
  1.4.3 Corticosteroids
  1.4.4 Thrombopoietin Receptor Agonists
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global Immune Thrombocytopenia Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospitals and Clinics
  1.5.3 Specialty Centers
  1.5.4 Research and Academic Institutes
  1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Immune Thrombocytopenia Treatment Market Perspective (2015-2026)
2.2 Immune Thrombocytopenia Treatment Growth Trends by Regions
  2.2.1 Immune Thrombocytopenia Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Immune Thrombocytopenia Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Immune Thrombocytopenia Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Immune Thrombocytopenia Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Immune Thrombocytopenia Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Immune Thrombocytopenia Treatment Players by Market Size
  3.1.1 Global Top Immune Thrombocytopenia Treatment Players by Revenue (2015-2020)
  3.1.2 Global Immune Thrombocytopenia Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Immune Thrombocytopenia Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Immune Thrombocytopenia Treatment Market Concentration Ratio
  3.2.1 Global Immune Thrombocytopenia Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Immune Thrombocytopenia Treatment Revenue in 2019
3.3 Immune Thrombocytopenia Treatment Key Players Head office and Area Served
3.4 Key Players Immune Thrombocytopenia Treatment Product Solution and Service
3.5 Date of Enter into Immune Thrombocytopenia Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Immune Thrombocytopenia Treatment Historic Market Size by Type (2015-2020)
4.2 Global Immune Thrombocytopenia Treatment Forecasted Market Size by Type (2021-2026)

5 IMMUNE THROMBOCYTOPENIA TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Immune Thrombocytopenia Treatment Market Size by Application (2015-2020)
5.2 Global Immune Thrombocytopenia Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Immune Thrombocytopenia Treatment Market Size (2015-2020)
6.2 Immune Thrombocytopenia Treatment Key Players in North America (2019-2020)
6.3 North America Immune Thrombocytopenia Treatment Market Size by Type (2015-2020)
6.4 North America Immune Thrombocytopenia Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Immune Thrombocytopenia Treatment Market Size (2015-2020)
7.2 Immune Thrombocytopenia Treatment Key Players in Europe (2019-2020)
7.3 Europe Immune Thrombocytopenia Treatment Market Size by Type (2015-2020)
7.4 Europe Immune Thrombocytopenia Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Immune Thrombocytopenia Treatment Market Size (2015-2020)
8.2 Immune Thrombocytopenia Treatment Key Players in China (2019-2020)
8.3 China Immune Thrombocytopenia Treatment Market Size by Type (2015-2020)
8.4 China Immune Thrombocytopenia Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Immune Thrombocytopenia Treatment Market Size (2015-2020)
9.2 Immune Thrombocytopenia Treatment Key Players in Japan (2019-2020)
9.3 Japan Immune Thrombocytopenia Treatment Market Size by Type (2015-2020)
9.4 Japan Immune Thrombocytopenia Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Immune Thrombocytopenia Treatment Market Size (2015-2020)
10.2 Immune Thrombocytopenia Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Immune Thrombocytopenia Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Immune Thrombocytopenia Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Immune Thrombocytopenia Treatment Market Size (2015-2020)
11.2 Immune Thrombocytopenia Treatment Key Players in India (2019-2020)
11.3 India Immune Thrombocytopenia Treatment Market Size by Type (2015-2020)
11.4 India Immune Thrombocytopenia Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Immune Thrombocytopenia Treatment Market Size (2015-2020)
12.2 Immune Thrombocytopenia Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Immune Thrombocytopenia Treatment Market Size by Type (2015-2020)
12.4 Central & South America Immune Thrombocytopenia Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 CSL
  13.1.1 CSL Company Details
  13.1.2 CSL Business Overview and Its Total Revenue
  13.1.3 CSL Immune Thrombocytopenia Treatment Introduction
  13.1.4 CSL Revenue in Immune Thrombocytopenia Treatment Business (2015-2020))
  13.1.5 CSL Recent Development
13.2 Amgen
  13.2.1 Amgen Company Details
  13.2.2 Amgen Business Overview and Its Total Revenue
  13.2.3 Amgen Immune Thrombocytopenia Treatment Introduction
  13.2.4 Amgen Revenue in Immune Thrombocytopenia Treatment Business (2015-2020)
  13.2.5 Amgen Recent Development
13.3 F.Hoffmann-La Roche
  13.3.1 F.Hoffmann-La Roche Company Details
  13.3.2 F.Hoffmann-La Roche Business Overview and Its Total Revenue
  13.3.3 F.Hoffmann-La Roche Immune Thrombocytopenia Treatment Introduction
  13.3.4 F.Hoffmann-La Roche Revenue in Immune Thrombocytopenia Treatment Business (2015-2020)
  13.3.5 F.Hoffmann-La Roche Recent Development
13.4 Kyowa Hakko Kirin
  13.4.1 Kyowa Hakko Kirin Company Details
  13.4.2 Kyowa Hakko Kirin Business Overview and Its Total Revenue
  13.4.3 Kyowa Hakko Kirin Immune Thrombocytopenia Treatment Introduction
  13.4.4 Kyowa Hakko Kirin Revenue in Immune Thrombocytopenia Treatment Business (2015-2020)
  13.4.5 Kyowa Hakko Kirin Recent Development
13.5 Rigel Pharmaceuticals
  13.5.1 Rigel Pharmaceuticals Company Details
  13.5.2 Rigel Pharmaceuticals Business Overview and Its Total Revenue
  13.5.3 Rigel Pharmaceuticals Immune Thrombocytopenia Treatment Introduction
  13.5.4 Rigel Pharmaceuticals Revenue in Immune Thrombocytopenia Treatment Business (2015-2020)
  13.5.5 Rigel Pharmaceuticals Recent Development
13.6 Shionogi
  13.6.1 Shionogi Company Details
  13.6.2 Shionogi Business Overview and Its Total Revenue
  13.6.3 Shionogi Immune Thrombocytopenia Treatment Introduction
  13.6.4 Shionogi Revenue in Immune Thrombocytopenia Treatment Business (2015-2020)
  13.6.5 Shionogi Recent Development
13.7 Dova Pharmaceuticals
  13.7.1 Dova Pharmaceuticals Company Details
  13.7.2 Dova Pharmaceuticals Business Overview and Its Total Revenue
  13.7.3 Dova Pharmaceuticals Immune Thrombocytopenia Treatment Introduction
  13.7.4 Dova Pharmaceuticals Revenue in Immune Thrombocytopenia Treatment Business (2015-2020)
  13.7.5 Dova Pharmaceuticals Recent Development
13.8 Novartis
  13.8.1 Novartis Company Details
  13.8.2 Novartis Business Overview and Its Total Revenue
  13.8.3 Novartis Immune Thrombocytopenia Treatment Introduction
  13.8.4 Novartis Revenue in Immune Thrombocytopenia Treatment Business (2015-2020)
  13.8.5 Novartis Recent Development
13.9 Jiangsu Hengrui Pharmaceutical
  13.9.1 Jiangsu Hengrui Pharmaceutical Company Details
  13.9.2 Jiangsu Hengrui Pharmaceutical Business Overview and Its Total Revenue
  13.9.3 Jiangsu Hengrui Pharmaceutical Immune Thrombocytopenia Treatment Introduction
  13.9.4 Jiangsu Hengrui Pharmaceutical Revenue in Immune Thrombocytopenia Treatment Business (2015-2020)
  13.9.5 Jiangsu Hengrui Pharmaceutical Recent Development
13.10 Takeda
  13.10.1 Takeda Company Details
  13.10.2 Takeda Business Overview and Its Total Revenue
  13.10.3 Takeda Immune Thrombocytopenia Treatment Introduction
  13.10.4 Takeda Revenue in Immune Thrombocytopenia Treatment Business (2015-2020)
  13.10.5 Takeda Recent Development
13.11 Ligand Pharmaceuticals
  10.11.1 Ligand Pharmaceuticals Company Details
  10.11.2 Ligand Pharmaceuticals Business Overview and Its Total Revenue
  10.11.3 Ligand Pharmaceuticals Immune Thrombocytopenia Treatment Introduction
  10.11.4 Ligand Pharmaceuticals Revenue in Immune Thrombocytopenia Treatment Business (2015-2020)
  10.11.5 Ligand Pharmaceuticals Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Immune Thrombocytopenia Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Immune Thrombocytopenia Treatment Revenue
Table 3. Ranking of Global Top Immune Thrombocytopenia Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Immune Thrombocytopenia Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Intravenous Immunoglobulins
Table 6. Key Players of Corticosteroids
Table 7. Key Players of Thrombopoietin Receptor Agonists
Table 8. Key Players of Others
Table 9. Global Immune Thrombocytopenia Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Immune Thrombocytopenia Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Immune Thrombocytopenia Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Immune Thrombocytopenia Treatment Market Share by Regions (2015-2020)
Table 13. Global Immune Thrombocytopenia Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Immune Thrombocytopenia Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Immune Thrombocytopenia Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Immune Thrombocytopenia Treatment Players
Table 20. Global Immune Thrombocytopenia Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Immune Thrombocytopenia Treatment Market Share by Players (2015-2020)
Table 22. Global Top Immune Thrombocytopenia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Thrombocytopenia Treatment as of 2019)
Table 23. Global Immune Thrombocytopenia Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Immune Thrombocytopenia Treatment Product Solution and Service
Table 26. Date of Enter into Immune Thrombocytopenia Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Immune Thrombocytopenia Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Immune Thrombocytopenia Treatment Market Size Share by Type (2015-2020)
Table 30. Global Immune Thrombocytopenia Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Immune Thrombocytopenia Treatment Market Size Share by Application (2015-2020)
Table 32. Global Immune Thrombocytopenia Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Immune Thrombocytopenia Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Immune Thrombocytopenia Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Immune Thrombocytopenia Treatment Market Share (2019-2020)
Table 36. North America Immune Thrombocytopenia Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Immune Thrombocytopenia Treatment Market Share by Type (2015-2020)
Table 38. North America Immune Thrombocytopenia Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Immune Thrombocytopenia Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Immune Thrombocytopenia Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Immune Thrombocytopenia Treatment Market Share (2019-2020)
Table 42. Europe Immune Thrombocytopenia Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Immune Thrombocytopenia Treatment Market Share by Type (2015-2020)
Table 44. Europe Immune Thrombocytopenia Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Immune Thrombocytopenia Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Immune Thrombocytopenia Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Immune Thrombocytopenia Treatment Market Share (2019-2020)
Table 48. China Immune Thrombocytopenia Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Immune Thrombocytopenia Treatment Market Share by Type (2015-2020)
Table 50. China Immune Thrombocytopenia Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Immune Thrombocytopenia Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Immune Thrombocytopenia Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Immune Thrombocytopenia Treatment Market Share (2019-2020)
Table 54. Japan Immune Thrombocytopenia Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Immune Thrombocytopenia Treatment Market Share by Type (2015-2020)
Table 56. Japan Immune Thrombocytopenia Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Immune Thrombocytopenia Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Immune Thrombocytopenia Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Immune Thrombocytopenia Treatment Market Share (2019-2020)
Table 60. Southeast Asia Immune Thrombocytopenia Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Immune Thrombocytopenia Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Immune Thrombocytopenia Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Immune Thrombocytopenia Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Immune Thrombocytopenia Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Immune Thrombocytopenia Treatment Market Share (2019-2020)
Table 66. India Immune Thrombocytopenia Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Immune Thrombocytopenia Treatment Market Share by Type (2015-2020)
Table 68. India Immune Thrombocytopenia Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Immune Thrombocytopenia Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Immune Thrombocytopenia Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Immune Thrombocytopenia Treatment Market Share (2019-2020)
Table 72. Central & South America Immune Thrombocytopenia Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Immune Thrombocytopenia Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Immune Thrombocytopenia Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Immune Thrombocytopenia Treatment Market Share by Application (2015-2020)
Table 76. CSL Company Details
Table 77. CSL Business Overview
Table 78. CSL Product
Table 79. CSL Revenue in Immune Thrombocytopenia Treatment Business (2015-2020) (Million US$)
Table 80. CSL Recent Development
Table 81. Amgen Company Details
Table 82. Amgen Business Overview
Table 83. Amgen Product
Table 84. Amgen Revenue in Immune Thrombocytopenia Treatment Business (2015-2020) (Million US$)
Table 85. Amgen Recent Development
Table 86. F.Hoffmann-La Roche Company Details
Table 87. F.Hoffmann-La Roche Business Overview
Table 88. F.Hoffmann-La Roche Product
Table 89. F.Hoffmann-La Roche Revenue in Immune Thrombocytopenia Treatment Business (2015-2020) (Million US$)
Table 90. F.Hoffmann-La Roche Recent Development
Table 91. Kyowa Hakko Kirin Company Details
Table 92. Kyowa Hakko Kirin Business Overview
Table 93. Kyowa Hakko Kirin Product
Table 94. Kyowa Hakko Kirin Revenue in Immune Thrombocytopenia Treatment Business (2015-2020) (Million US$)
Table 95. Kyowa Hakko Kirin Recent Development
Table 96. Rigel Pharmaceuticals Company Details
Table 97. Rigel Pharmaceuticals Business Overview
Table 98. Rigel Pharmaceuticals Product
Table 99. Rigel Pharmaceuticals Revenue in Immune Thrombocytopenia Treatment Business (2015-2020) (Million US$)
Table 100. Rigel Pharmaceuticals Recent Development
Table 101. Shionogi Company Details
Table 102. Shionogi Business Overview
Table 103. Shionogi Product
Table 104. Shionogi Revenue in Immune Thrombocytopenia Treatment Business (2015-2020) (Million US$)
Table 105. Shionogi Recent Development
Table 106. Dova Pharmaceuticals Company Details
Table 107. Dova Pharmaceuticals Business Overview
Table 108. Dova Pharmaceuticals Product
Table 109. Dova Pharmaceuticals Revenue in Immune Thrombocytopenia Treatment Business (2015-2020) (Million US$)
Table 110. Dova Pharmaceuticals Recent Development
Table 111. Novartis Business Overview
Table 112. Novartis Product
Table 113. Novartis Company Details
Table 114. Novartis Revenue in Immune Thrombocytopenia Treatment Business (2015-2020) (Million US$)
Table 115. Novartis Recent Development
Table 116. Jiangsu Hengrui Pharmaceutical Company Details
Table 117. Jiangsu Hengrui Pharmaceutical Business Overview
Table 118. Jiangsu Hengrui Pharmaceutical Product
Table 119. Jiangsu Hengrui Pharmaceutical Revenue in Immune Thrombocytopenia Treatment Business (2015-2020) (Million US$)
Table 120. Jiangsu Hengrui Pharmaceutical Recent Development
Table 121. Takeda Company Details
Table 122. Takeda Business Overview
Table 123. Takeda Product
Table 124. Takeda Revenue in Immune Thrombocytopenia Treatment Business (2015-2020) (Million US$)
Table 125. Takeda Recent Development
Table 126. Ligand Pharmaceuticals Company Details
Table 127. Ligand Pharmaceuticals Business Overview
Table 128. Ligand Pharmaceuticals Product
Table 129. Ligand Pharmaceuticals Revenue in Immune Thrombocytopenia Treatment Business (2015-2020) (Million US$)
Table 130. Ligand Pharmaceuticals Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Immune Thrombocytopenia Treatment Market Share by Type: 2020 VS 2026
Figure 2. Intravenous Immunoglobulins Features
Figure 3. Corticosteroids Features
Figure 4. Thrombopoietin Receptor Agonists Features
Figure 5. Others Features
Figure 6. Global Immune Thrombocytopenia Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Specialty Centers Case Studies
Figure 9. Research and Academic Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. Immune Thrombocytopenia Treatment Report Years Considered
Figure 12. Global Immune Thrombocytopenia Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Immune Thrombocytopenia Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Immune Thrombocytopenia Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Immune Thrombocytopenia Treatment Market Share by Players in 2019
Figure 17. Global Top Immune Thrombocytopenia Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Immune Thrombocytopenia Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Immune Thrombocytopenia Treatment Revenue in 2019
Figure 19. North America Immune Thrombocytopenia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Immune Thrombocytopenia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Immune Thrombocytopenia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Immune Thrombocytopenia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Immune Thrombocytopenia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Immune Thrombocytopenia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Immune Thrombocytopenia Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. CSL Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. CSL Revenue Growth Rate in Immune Thrombocytopenia Treatment Business (2015-2020)
Figure 28. Amgen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Amgen Revenue Growth Rate in Immune Thrombocytopenia Treatment Business (2015-2020)
Figure 30. F.Hoffmann-La Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. F.Hoffmann-La Roche Revenue Growth Rate in Immune Thrombocytopenia Treatment Business (2015-2020)
Figure 32. Kyowa Hakko Kirin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Kyowa Hakko Kirin Revenue Growth Rate in Immune Thrombocytopenia Treatment Business (2015-2020)
Figure 34. Rigel Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Rigel Pharmaceuticals Revenue Growth Rate in Immune Thrombocytopenia Treatment Business (2015-2020)
Figure 36. Shionogi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Shionogi Revenue Growth Rate in Immune Thrombocytopenia Treatment Business (2015-2020)
Figure 38. Dova Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Dova Pharmaceuticals Revenue Growth Rate in Immune Thrombocytopenia Treatment Business (2015-2020)
Figure 40. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Novartis Revenue Growth Rate in Immune Thrombocytopenia Treatment Business (2015-2020)
Figure 42. Jiangsu Hengrui Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Jiangsu Hengrui Pharmaceutical Revenue Growth Rate in Immune Thrombocytopenia Treatment Business (2015-2020)
Figure 44. Takeda Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Takeda Revenue Growth Rate in Immune Thrombocytopenia Treatment Business (2015-2020)
Figure 46. Ligand Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Ligand Pharmaceuticals Revenue Growth Rate in Immune Thrombocytopenia Treatment Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed